Can we afford not to offer screening? 

Discover how early detection and intelligent solutions can fundamentally improve lung cancer care.

Early detection

Lung cancer has the highest mortality rate of all cancers and one of the worst five year survival rates of all cancers at 17% for men and 22% for women.[1] What makes lung cancer so deadly is that the symptoms are non-specific, and patients often only come to the clinic when tumors have exceeded a critical size or when cancer cells have attacked the lymph nodes or have metastasized. The only chance of a cure is to diagnose lung cancer as early as possible. Early detection and the introduction of screening programs have the potential to fundamentally improve lung cancer healthcare. Although treatment for advanced tumor stages, such as immunotherapy, works well, it is also very expensive and a significant burden for the healthcare system. The cost per life saved by a screening program is therefore much lower.

Accompany a young female lung cancer patient in Taiwan on her journey after having received a lung cancer diagnosis. See how early detection and minimally invasive, image-guided thoracoscopic surgery can provide hope.

Lung Cancer Screening Stage Shift

Sebastian Schmidt


Marie-Pierre Revel

The life-saving potential of early lung cancer detection is increasingly recognized, and individual countries have already started to implement screening programs. What can we learn from these countries?

Prof. Herth

Barbara Baysal from the German Self-Help Lung Cancer Association (Bundesverband Selbsthilfe Lungenkrebs e.V.) talks about her expectations of a screening program for lung cancer, how it should be designed from the patient‘s point of view, and what we can learn from other screening programs.


Barbara Baysal

Why do we need lung cancer screening and which patients are eligible? Prof. Dr. Jens Vogel-Claussen shares his view and, as head of the HANSE study, provides insights into his findings to date.

Portrait Prof-Dr-Jens-Vogel-Claussen

Therapy

Treatment of lung cancer

Depending on the stage and cancer type, the treatment could be surgery, chemo, radiation or immunotherapy. With the introduction of lung cancer screening, more cases are expected to be discovered in an earlier stage. Therefore, the current therapy mix of surgery, radiation therapy and chemotherapy will probably change to less invasive methods where imaging might also play a bigger role. Key-hole surgery, stereotactic radiation therapy and local ablation techniques and combinations may become more important.

elderly woman with jacket
lung cancer product portfolio

Noona® is a patient outcome management solution designed to engage patients in their care with real-time symptom reporting and monitoring, streamlined clinical workflows to promote evidence-based care and access to rich data insights for better management and ongoing assessment over the course of care.

Lung cancer is the leading cause of cancer death in Taiwan. Chi Mei Medical Center, located in the city of Tainan, is able to provide cutting-edge minimally invasive procedures thanks to a hybrid OR equipped with ARTIS pheno. Yao Fong, Head of Thoracic Surgery, says that the high-end robotic imaging system has allowed him and his team to improve lung cancer therapies and develop new treatment approaches.

Photon-counting CT

Computed tomography can be used to detect tissue changes in the lungs. Photon-counting CT provides valuable additional information: cinematic rendering based on monoenergetic images (left), fusion of perfusion information and anatomy acquired at the same time (middle), and cinematic volume rendering based on contrast media perfusion extracted from the spectral information (right).


Professor Dr. med. Heinz-Peter Schlemmer DKFZ

What's next

What does the future of cancer care look like?

Learn how the digital twin of the patient could lead to early detection of cancer in the future using AI technology and medical expertise. Health data integration could enable personalized care even before hospitalization to achieve the best possible patient-reported outcomes.

In this video, a possible future of intelligent cancer care is demonstrated to expand the frontier in oncology.